Početna › Ateroskleroza › Washington
Kliničke studije za Ateroskleroza u državi Washington
6 studija za Ateroskleroza traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Eastside Research Associates, LLC dba Era Health Research, Redmond
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- ERA Health Research - CardioNow - Lynnwood, Lynnwood
- Eastside Research Associates, Redmond
- Rainier Clinical Research Center, Renton
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- VA Puget Sound Healthcare System, Seattle
- Velocity Clinical Research - Spokane, Spokane
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
U tijeku regrutacijaFaza 3
Od 45 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07613294A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357Pelacarsen Roll-over Extension Program
- University of Washington, Seattle
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06875973Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.